Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats

Journal of Nanoscience and Nanotechnology

Volumn 8, Issue 5, 2008, Pages 2422-2431

  Wang, Xue Qing ^a   Dai, Jun Dong ^a   Zhang, Hua ^a   Zhang, Xuan ^a   Wang, Jian Cheng ^a   Zhang, Qiang ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Absorption mechanism; Cyclosporine A; Gastro intestinal tract; pH sensitive nanoparticles; Rat

Indexed keywords

DEGRADATION; DRUG DOSAGE; DRUG PRODUCTS; GLYCOPROTEINS; MICROEMULSIONS; NANOPARTICLES; PH SENSORS; RATING; RATS;

ABSORPTION MECHANISMS; ABSORPTION SITES; CYCLOSPORINE A; DEGRADATION RATE; GASTROINTESTINAL TRACT; PH SENSITIVE; SMALL INTESTINE; SUBCELLULAR FRACTIONS;

DRUG DELIVERY;

CYCLOSPORIN; NANOPARTICLE;

ANIMAL; ARTICLE; CELL STRAIN CACO 2; HUMAN; ORAL DRUG ADMINISTRATION; PH; RAT;

ADMINISTRATION, ORAL; ANIMALS; CACO-2 CELLS; CYCLOSPORINE; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; RATS;

EID: 47149110223     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. A. D. Rieux, V. Fievez, M. Garinot, Y. J. Schneider, and V. Préat, J. Contr. Rel. 116, 1 (2006).
2. X. Y. Yan, X. T. Wang, X. N. Zhang, and Q. Zhang, J. Pharmco. Exp. Ther. 116, 774 (2004).
3. S. M. Merwe, J. C. Verhoef, J. H. Verheijden, A. F. Kotze, and H. E. Junginger, Eur. J. Pharm. Biopharm. 58, 225 (2004).
4. C. M. Kruijtzer, J. H. Beijnen, H. Rosing, W. W. Bokkel Huinink, M. Schot, R. C. Jewell, E. M. Paul, and J. H. Schellens, J. Clin. Oncol. 20, 2943 (2002).
5. D. R. Friend, Adv. Drug. Del. Rev. 1, 149 (1991).
6. A. Ezra, A. Hoffman, E. Breuer, I. S. Alferiev, and J. Mönkkönen, J. Med. Chem. 43, 3641 (2000).
7. S. T. Dogru, S. Calis, and F. Oner, J. Clin. Pharm. Ther. 25, 435 (2000).
8. H. Takeuchi, Y. Matsui, H. Sugihara, H. Yamamoto, and Y. Kawashima, Int. J. Pharm. 303, 160 (2005).
9. C. Dai, B. Wang, H. Zhao, B. Li, and J. Wang, Colloids Surf. B Biointerfaces 47, 205 (2006).
10. T. Akagi, T. Kaneko, T. Kida, and M. Akashi, J. Contr. Rel. 108, 226 (2005).
11. W. Kramer, G. Wess, A. Enhsen, E. Falk, A. Hoffmann, G. Neckermann, G. Schubert, and M. Urmann, J. Contr. Rel. 46, 17 (1997).
12. M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Levy, Pharm. Res. 13, 1838 (1996).
13. Q. Z. Wu and Q. N. Ping, Journal of China Pharmaceutical University 33, 192 (2002).
14. S. Sakuma, M. Hayashi, and M. Akashi, Adv. Drug. Del. Rev. 47, 21 (2001).
15. M. H. El-Shabouri, Int. J. Pharm. 249, 11 (2002).
16. X. Q. Wang, J. D. Dai, Z. Chen, T. Zhang, G. M. Xia, T. Nagai, and Q. Zhang, J. Contr. Rel. 91, 421 (2004).
17. J. D. Dai, T. Nagai, X. Q. Wang, T. Zhang, M. Meng, and Q. Zhang, Int. J. Pharm. 280, 229 (2004).
18. D. R. Luke, B. L. Kasiske, G. R. Matzke, W. M. Awni, and W. F. Keane, Transplantation 43, 795 (1987).
19. T. Cavanak and H. Sucker, Prog. Allergy 38, 65 (1986).
20. J. S. Woo, M. G. Piao, D. X. Li, D. S. Ryu, J. Y. Choi, J. A. Kim, J. H. Kim, S. G. Jin, D. D. Kim, W. S. Lyoo, C. S. Yong, and H. G. Choi, Int. J. Pharm. 345, 134 (2007).
21. A. Fahr, P. V. Hoogevest, S. May, N. Bergstrand, and M. L. S. Leigh, Eur. J. Pharm. Sci. 26, 251 (2005).
22. K. Toshikiro, M. Yusuke, O. Misako, O. Seiji, and H. Kazutaka, J. Pharmco. Exp. Ther. 283, 611 (1997).
23. H. Asada, T. Douen, Y. Mizukoshi, T. Fujita, M. Murakami, A. Yamamoto, and S. Muranishi, Pharm. Res. (NY) 11, 1115 (1994).
24. J. P. F. Bai and L. L. Chang, Pharm. Res. (NY) 12, 1171 (1995).
25. Y. Miyazaki, K. Ogihara, S. Yakou, T. Nagai, and K. Takayama, Int. J. Pharm. 258, 21 (2003).
26. A. Adson, T. J. Raub, P. S. Burton, C. L. Barsuhn, A. R. Hilgers, K. L. Audus, and N. F. Ho, J. Pharm. Sci. 83, 1529 (1994).
27. K. Morimoto, H. Yamahara, V. H. L. Lee, and K. J. Kim, Pharm. Res. 10, 1668 (1993).
28. A. R. Johnson, R. A. Skidgel, J. T. Gafford, and E. G. Erdos, Peptides 5, 789 (1984).